Allergan Acquires AqueSys for $300,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    26970 Aliso Viejo Pkwy Aliso Viejo, CA 92656 USA
  • Company Description
    The company is developing a device treatment for primary open angle glaucoma.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under the terms of the agreement, Allergan will acquire AqueSys for a $300 million upfront payment and regulatory approval and commercialization milestone payments related to AqueSys’ lead development programs, including XEN45.

Trending on Xconomy